Enzo Biochem's basic earnings per share (Basic EPS) for the
three
months ended in Jan. 2024 was $-0.06.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2024 was $0.67.
Enzo Biochem's EPS (Diluted) for the
three
months ended in Jan. 2024 was $-0.06.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $0.67.
Enzo Biochem's EPS without NRI for the
three
months ended in Jan. 2024 was $-0.02.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was -0.07.
During the past 3 years, the average EPS without NRIGrowth Rate was 12.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Enzo Biochem's highest 3-Year average EPS without NRI Growth Rate was 54.10% per year. The lowest was -231.40% per year. And the median was 11.80% per year.
Enzo Biochem EPS (Basic) Historical Data
The historical data trend for Enzo Biochem's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Enzo Biochem's Basic EPS for the fiscal year that ended in Jul. 2023 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem (NYSE:ENZ) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Enzo Biochem EPS (Basic) Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 